Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Michael Mena
Michael T. Mena is a publicist with Ileana International. He has written articles for Hispanic Business News, Billboard Magazine, the Grammy Magazine and the Easy Reader News amongst others. You can find out more about bird's nest products at www.blessingbirdnest.com.